Login / Signup
Guselkumab vs. secukinumab for the treatment of moderate-to-severe psoriasis: a critical appraisal.
Marilyn T Wan
Junko Takeshita
Published in:
The British journal of dermatology (2020)
Keyphrases
</>
ankylosing spondylitis
early onset
high intensity
systemic lupus erythematosus
drug induced